User menu

Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection.

Bibliographic reference Horsmans, Yves ; Berg, Thomas ; Desager, Jean-Pierre ; Mueller, Tobias ; Schott, Eckart ; et. al. Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection.. In: Hepatology (Baltimore, Md.), Vol. 42, no. 3, p. 724-31 (2005)
Permanent URL http://hdl.handle.net/2078.1/10303
  1. Strader, HEPATOLOGY, 39, 1147 (2004)
  2. Poynard, Lancet, 362, 2095 (2003)
  3. Gastroenterology, 123, 2082 (2002)
  4. Strader, Eur J Gastroenterol Hepatol, 8, 324 (1996)
  5. Manns, Lancet, 358, 958 (2001)
  6. Fried, N Engl J Med, 347, 975 (2002)
  7. Pawlotsky, HEPATOLOGY, 39, 554 (2004)
  8. Lindenbach, HEPATOLOGY, 38, 769 (2003)
  9. Trozzi, J Virol, 77, 3669 (2003)
  10. Janeway, Annu Rev Immunol, 20, 197 (2002)
  11. Netea, J Leukoc Biol, 75, 749 (2004)
  12. Beutler, Nature, 430, 257 (2004)
  13. O'Neill, Science, 303, 1481 (2004)
  14. Lee, Proc Natl Acad Sci U S A, 100, 6646 (2003)
  15. Heil, Eur J Immunol, 33, 2987 (2003)
  16. Akira, Immunol Lett, 85, 85 (2003)
  17. Hemmi, Nat Immunol, 3, 196 (2002)
  18. Nagahara, J Med Chem, 33, 407 (1990)
  19. Smee D F, Alaghamandan H A, Cottam H B, Sharma B S, Jolley W B, Robins R K, Broad-spectrum in vivo antiviral activity of 7-thia-8-oxoguanosine, a novel immunopotentiating agent., 10.1128/aac.33.9.1487
  20. Smee, J Biol Response Mod, 9, 24 (1990)
  21. Smee, Antiviral Res, 15, 229 (1991)
  22. Buti, HEPATOLOGY, 35, 930 (2002)
  23. Glue, Clin Pharmacol Ther, 68, 556 (2000)
  24. Herrmann, HEPATOLOGY, 37, 1351 (2003)
  25. Bruno, Antivir Ther, 9, 491 (2004)
  26. Solinas Antonio, Cossu Pierangela, Poddighe Paola, Tocco Andreina, Deplano Angelo, Garrucciu Giovanni, Diana Maria Silvana Antonolla, Changes of serum 2‘,5’-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis C, 10.1111/j.1600-0676.1993.tb00640.x
  27. Schenker, J Interferon Cytokine Res, 17, 665 (1997)
  28. Murashima, J Med Virol, 62, 185 (2000)
  29. MacQuillan, J Med Virol, 70, 219 (2003)
  30. Murr, Curr Drug Metab, 3, 175 (2002)
  31. Dufour J. H., Dziejman M., Liu M. T., Leung J. H., Lane T. E., Luster A. D., IFN- -Inducible Protein 10 (IP-10; CXCL10)-Deficient Mice Reveal a Role for IP-10 in Effector T Cell Generation and Trafficking, 10.4049/jimmunol.168.7.3195
  32. Khakoo, Br J Clin Pharmacol, 46, 563 (1998)
  33. Hong Zhi, Cameron Craig E., Pleiotropic mechanisms of ribavirin antiviral activities, Progress in Drug Research (2002) ISBN:9783034894647 p.41-69, 10.1007/978-3-0348-8171-5_2
  34. Hong, HEPATOLOGY, 38, 807 (2003)
  35. Vollmer, Antimicrob Agents Chemother, 48, 2314 (2004)
  36. De Clercq, J Clin Virol, 30, 115 (2004)
  37. Pockros, HEPATOLOGY, 37, 1368 (2003)
  38. Wichers, Int J Neuropsychopharmacol, 5, 375 (2002)
  39. Zuany-Amorim, Nat Rev Drug Discov, 1, 797 (2002)
  40. Lawton, Curr Opin Chem Biol, 7, 446 (2003)
  41. O'Neill, Curr Opin Pharmacol, 3, 396 (2003)
  42. Tran, Expert Opin Pharmacother, 5, 427 (2004)
  43. Pockros, Gastroenterology, 124, 76a (2003)